Your browser doesn't support javascript.
loading
Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome.
Yokomizo-Nakano, Takako; Kubota, Sho; Bai, Jie; Hamashima, Ai; Morii, Mariko; Sun, Yuqi; Katagiri, Seiichiro; Iimori, Mihoko; Kanai, Akinori; Tanaka, Daiki; Oshima, Motohiko; Harada, Yuka; Ohyashiki, Kazuma; Iwama, Atsushi; Harada, Hironori; Osato, Motomi; Sashida, Goro.
Afiliação
  • Yokomizo-Nakano T; Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto Japan.
  • Kubota S; Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto Japan.
  • Bai J; Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto Japan.
  • Hamashima A; Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto Japan.
  • Morii M; Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto Japan.
  • Sun Y; Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto Japan.
  • Katagiri S; Department of Hematology, Tokyo Medical University, Tokyo, Japan.
  • Iimori M; Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto Japan.
  • Kanai A; Department of Molecular Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Tanaka D; Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto Japan.
  • Oshima M; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo Japan.
  • Harada Y; Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Ohyashiki K; Department of Hematology, Tokyo Medical University, Tokyo, Japan.
  • Iwama A; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo Japan.
  • Harada H; Laboratory of Oncology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Osato M; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Sashida G; Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto Japan. sashidag@kumamoto-u.ac.jp.
Cancer Res ; 80(12): 2523-2536, 2020 06 15.
Article em En | MEDLINE | ID: mdl-32341038
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Células-Tronco Hematopoéticas / Transformação Celular Neoplásica / Subunidade alfa 2 de Fator de Ligação ao Core / Subunidade alfa 3 de Fator de Ligação ao Core Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Células-Tronco Hematopoéticas / Transformação Celular Neoplásica / Subunidade alfa 2 de Fator de Ligação ao Core / Subunidade alfa 3 de Fator de Ligação ao Core Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article